Federal Court of Appeal upholds Federal Court decision finding Shire’s VYVANSE patent valid

Published date02 April 2021
Subject MatterPatents,Appeals,Obviousness,Dismissals,Patent Litigation,Pharmaceutical Patents,Canada,Patent Infringement,Apotex,Patent Validity,Anticipation,Notice of Compliance,Minister of Health
AuthorAndrea Berenbaum
Law FirmSmart & Biggar

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT